Literature DB >> 2279061

In vitro model for the degradation of alkylcyanoacrylate nanoparticles.

R H Müller1, C Lherm, J Herbort, P Couvreur.   

Abstract

A photometric assay was developed to study the surface erosion of polymeric nanoparticles. The hydrolytic degradation of polyalkylcyanoacrylate particles was studied in different environments (NaOH, buffer, cell culture medium and serum). The influence of particle modification on the degradation rate was assessed. Particularly, the effect of polymer coating for particle targeting and fluorescence labelling was investigated. From the absorption data, a t50% and t100% can be calculated for fast degrading particles and obtained by an extrapolation in case of a slow degradation process. The degradation rate was found to decrease with increasing alkyl chain length from methyl-, ethyl-, isobutyl- to isohexylcyanoacrylate particles. Polymer coating and fluorescent labelling had little effect on the rate of degradation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2279061     DOI: 10.1016/0142-9612(90)90084-4

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  13 in total

1.  In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.

Authors:  Paul R Lockman; Joanna Koziara; Karen E Roder; Jennifer Paulson; Thomas J Abbruscato; Russell J Mumper; David D Allen
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

Review 2.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

Review 3.  Nanocarriers for tracking and treating diseases.

Authors:  Sean Marrache; Rakesh Kumar Pathak; Kasey L Darley; Joshua H Choi; Dhillon Zaver; Nagesh Kolishetti; Shanta Dhar
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

4.  Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer.

Authors:  M T Peracchia; C Vauthier; D Desmaële; A Gulik; J C Dedieu; M Demoy; J d'Angelo; P Couvreur
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

5.  Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity.

Authors:  J C Olivier; L Fenart; R Chauvet; C Pariat; R Cecchelli; W Couet
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

6.  Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides.

Authors:  G Lambert; E Fattal; H Pinto-Alphandary; A Gulik; P Couvreur
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

7.  The stenlying effect of high hydrostatic pressure on thermally and hydrolytically labile nanosized carriers.

Authors:  Irène Brigger; Laurence Armand-Lefevre; Pierre Chaminade; Madeleine Besnard; Yohan Rigaldie; Alain Largeteau; Antoine Andremont; Luc Grislain; Gérard Demazeau; Patrick Couvreur
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

8.  Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake.

Authors:  C Chavany; T Saison-Behmoaras; T Le Doan; F Puisieux; P Couvreur; C Hélène
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

Review 9.  Nano-Medicines a Hope for Chagas Disease!

Authors:  Satabdi Datta Choudhury
Journal:  Front Mol Biosci       Date:  2021-06-01

10.  Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles.

Authors:  Einar Sulheim; Habib Baghirov; Eva von Haartman; Andreas Bøe; Andreas K O Åslund; Yrr Mørch; Catharina de Lange Davies
Journal:  J Nanobiotechnology       Date:  2016-01-08       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.